Early Integration of Supportive Care for Metastatic Uveal Melanoma Patients (EarlyTogether)

Before the start of the study, medical oncologists and supportive care physicians from both the sites will attend Communication Skills Training (CST) workshops provided by an expert team in the field. The training sessions will focus on practicing the required communication skills needed in consultations.

The randomization will assign patients, with a 1:2 ratio, to "Introduction of supportive care when medically needed" (Arm A: Control Group) or "Initial concomitant management by the oncologist and the supportive care team" (Arm B: Early Together Group).

Selected and validated questionnaires will be filled at baseline, 6 and 12 months by the patients before the consultation, in the 2 groups.

Inclusion criteria

• adult patients with metastatic UM;
• no surgery or loco-regional treatment of metastases in a curative intent;
• systemic treatment planned or started since less than 2 months;
• ECOG PS 0-1;
• no uncontrolled symptoms;
• liver function tests in normal range or ≤ grade 2;
• signed informed consent;
• able to fill the questionnaires.

Exclusion criteria

• patient<18 years old;
• patient condition requiring supportive care before any systemic specific treatment for metastases;
• acute psychopathological disorder incompatible with the study;
• prior medical condition incompatible with the study.